STRS Ohio’s Acceleron Pharma XLRN Stock Holding History

STRS Ohio’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,033	Closed	-$882K	–	2366
2021 Q2	$882K	Buy	7,033 +975	+16%	+$123K	﹤0.01%	1246
2021 Q1	$821K	Sell	6,058 -317	-5%	-$40.9K	﹤0.01%	1302
2020 Q4	$815K	Sell	6,375 -2,011	-24%	-$236K	﹤0.01%	1189
2020 Q3	$943K	Buy	8,386 +659	+9%	+$65.6K	﹤0.01%	958
2020 Q2	$736K	Buy	7,727 +627	+9%	+$60.4K	﹤0.01%	1053
2020 Q1	$638K	Buy	7,100 +5,700	+407%	+$443K	﹤0.01%	957
2019 Q4	$74K	Buy	+1,400	New	+$63.8K	﹤0.01%	1831
2016 Q4	–	Sell	-8,700	Closed	-$314K	–	2013
2016 Q3	$314K	Sell	8,700 -8,100	-48%	-$268K	﹤0.01%	1452
2016 Q2	$570K	Buy	+16,800	New	+$546K	﹤0.01%	1241
2015 Q4	–	Sell	-12,500	Closed	-$311K	–	1976
2015 Q3	$311K	Hold	12,500	–	–	﹤0.01%	1430
2015 Q2	$395K	Hold	12,500	–	–	﹤0.01%	1407
2015 Q1	$475K	Hold	12,500	–	–	﹤0.01%	1224
2014 Q4	$487K	Buy	12,500 +4,900	+64%	+$171K	﹤0.01%	1213
2014 Q3	$230K	Buy	+7,600	New	+$214K	﹤0.01%	1432
2014 Q2	–	Sell	-1,600	Closed	-$55K	–	1788
2014 Q1	$55K	Sell	1,600 -1,000	-38%	-$45.1K	﹤0.01%	1610
2013 Q4	$103K	Buy	+2,600	New	+$62.8K	﹤0.01%	1562

Other funds holding XLRN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

STRS Ohio's XLRN Position: Q3 2021 in Review

STRS Ohio sold out of Acceleron Pharma (XLRN) in Q3 2021, closing a stake of 7,033 shares — an estimated $882K sold.

STRS Ohio first reported a position in XLRN in Q4 2013 and held it in 16 quarters. The position peaked at $943K in Q3 2020. 330 funds tracked by Wall St. Rank hold XLRN as of Q3 2021.

STRS Ohio reported no remaining Acceleron Pharma position as of Q3 2021 after selling out during the quarter.
STRS Ohio sold 7,033 Acceleron Pharma shares in Q3 2021, an estimated $882K.
STRS Ohio first reported a position in Acceleron Pharma in Q4 2013 and held it in 16 quarters.
STRS Ohio's Acceleron Pharma position peaked at $943K in Q3 2020.
330 funds tracked by Wall St. Rank held Acceleron Pharma as of Q3 2021.

Based on STRS Ohio's 13F filing for Q3 2021, filed 22 Oct 2021.